Aussie suffers get PBS boost for urinary issues

Lost in the RU486 announcement was the following:

The PBAC recommended extending the current Section 100 Botulinum Toxin Program listing for botulinum toxin type A to include the treatment of urinary incontinence due to neurogenic detrusor overactivity in patients with multiple sclerosis, spinal cord injury or adult spina bifida, who meet certain criteria, on the basis of acceptable cost-effectiveness compared to best supportive care.

Now, I don’t know what is the comparative best supportive care, but this has got to hoe good news, right?

Advertisements